EB-1A Approved: Four Real Case Studies and What Made the Difference

Why Case Studies Matter More Than Eligibility Checklists

Eligibility checklists tell you what the criteria are. They do not tell you how those criteria behave in practice — how they interact, where they are challenged, what makes the difference between an RFE and a clean approval.

Real case studies do that. The four cases in this article are composite illustrations built from actual EB-1A approval patterns. The names are fictional; the professional profiles, evidence strategies, challenges, and outcomes are drawn directly from the kinds of cases that have been approved under the regulatory standard. Every challenge described here reflects a real RFE trigger. Every winning strategy reflects evidence that has actually persuaded USCIS adjudicators.

Read these not as templates to imitate but as maps to calibrate your own reading of your situation. Your case will be different in its specifics. But the underlying principles — what USCIS cares about, where petitions are challenged, what tips a case toward approval — are consistent.

Case Study 1: Arjun Sharma — Staff Software Engineer, San Francisco (Approved in 4 Months, 3 Weeks)

Background: Arjun grew up in Bengaluru, India, completed his undergraduate degree in computer science at IIT Delhi, and came to the US for his master's and then a PhD at Carnegie Mellon. He spent seven years at Google and three at Meta, where he was promoted to Staff Software Engineer and eventually led the infrastructure team responsible for the recommendation system's serving layer. His total compensation in 2024 was $720,000 including base, bonus, and vested RSUs. He had four granted patents, 12 publications across top-tier systems and ML conferences, and had served on the program committees of SOSP and OSDI for three consecutive years each.

His EB-2 India priority date: January 2013. With backlog movement of roughly two to three months per calendar year, he was looking at twelve to fifteen years before a visa number would be available.

Criteria Claimed (Four):

Criterion 4 (Judging): Six consecutive years on program committees at SOSP and OSDI — two of the top three systems conferences globally. Each year, he reviewed fifteen to twenty paper submissions and participated in the committee discussion that determined what was accepted. The committee at SOSP consisted of 35 of the world's leading systems researchers.

Criterion 5 (Original Contributions): His 2020 SOSP paper on hierarchical cache coherence had been cited 312 times in four years, including adoption acknowledgments from two major cloud providers. One of his four patents had been licensed by an independent database company and was incorporated in their product.

Criterion 8 (Critical Role): He led a 22-person engineering team responsible for the infrastructure serving Meta's recommendation systems — a function described by Meta's CTO in a supporting letter as "central to approximately $30 billion in annual advertising revenue." The organization was established as distinguished through press coverage, Meta's public financial disclosures, and its listing among the world's largest technology companies.

Criterion 9 (High Salary): Total compensation of $720,000 compared against BLS OES data for Software Developers in the San Jose-Sunnyvale-Santa Clara MSA, where the 90th percentile was $210,000. A compensation consultant declaration confirmed the 98th percentile placement.

Evidence Package:

Five independent expert declarations from professors at Stanford, MIT, CMU, Berkeley, and a research scientist at Waymo. None had personally collaborated with Arjun. All had read his publications. Three had cited his work.

Citation analysis from Web of Science showing h-index of 14, placing him at the 86th percentile for researchers in his field at equivalent career stage.

Patent licensing documentation including the license agreement (redacted for confidentiality) and a public press release from the licensee company announcing the product that incorporated the patented technology.

Organizational documentation from Meta: org chart, CTO support letter, job description, and three years of performance reviews showing "Exceeds Expectations" and "Significantly Exceeds Expectations" ratings with scope descriptions.

BLS OES data for San Jose MSA printed directly from bls.gov, compared in a two-page salary analysis memo.

The RFE: None issued.

The Approval: Four months and three weeks from filing date. The approval notice specifically cited the depth of independent expert declarations and the citation benchmarking as particularly persuasive.

Key Lesson: Arjun had dismissed EB-1A for five years because he thought he was "not extraordinary enough." His achievements — measured against the legal standard, documented with quantification and context — clearly met it. The barrier was not his record; it was his self-perception. The petition did not exaggerate anything. It contextualized everything.

Case Study 2: Dr. Priya Nair — Oncology Researcher, Houston (Approved in 6 Months, 1 RFE)

Background: Priya grew up in Pune, Maharashtra, India, completed her MBBS at BJ Medical College, her PhD in molecular biology from IISc Bangalore, and her postdoctoral fellowship at MD Anderson Cancer Center in Houston. She joined the faculty there as an Assistant Professor in 2019. By 2024, she had 19 peer-reviewed publications, an h-index of 18, 900+ total citations, and had served on two NIH Study Section panels as a reviewer.

Her EB-2 India priority date: 2018. She had heard NIW described as "easier" and briefly considered it — but recognized that even an approved NIW would leave her waiting years for a visa number. EB-1A's EB-1 category moved faster.

Criteria Claimed (Four):

Criterion 4 (Judging): Service on two NIH Study Section review panels — among the most selective and consequential grant review panels in biomedical research. NIH letters confirmed her service, the panels' focus areas, and the approximate number of applications reviewed.

Criterion 5 (Original Contributions): Her 2021 paper in Nature Cancer on PARP inhibitor resistance mechanisms in triple-negative breast cancer had been cited 156 times in three years and was referenced in the current NCCN Clinical Practice Guidelines for TNBC — the gold standard guideline document in the field.

Criterion 6 (Scholarly Articles): 19 peer-reviewed publications in journals including Nature Cancer, Cancer Cell, Journal of Clinical Oncology, and Cancer Discovery — all among the most respected journals in oncology.

Criterion 8 (Critical Role): Principal Investigator on a $2.3 million NCI R01 grant, running a lab of six postdoctoral researchers, three graduate students, and a lab manager. A letter from the MD Anderson Cancer Center Director described her research program as one of 12 identified as institutional research priorities.

The RFE:

USCIS challenged Criterion 5, specifically questioning whether the NCCN guideline citation demonstrated "major significance" in the field or was merely one citation among many in a comprehensive guideline document. The RFE asked for additional evidence that the petitioner's contribution had materially influenced how practitioners approach TNBC treatment.

The Response:

Priya's response team obtained: two new independent expert declarations from senior oncologists (one at Memorial Sloan Kettering, one at Dana-Farber Cancer Center) specifically addressing the clinical significance of the NCCN guideline incorporation; a letter from the NCCN guideline panel chair explaining that the guideline section citing Priya's research represented a change in clinical practice recommendations, not merely a literature reference; and updated citation analysis showing that the 2021 paper had been cited in 18 subsequent clinical trial design papers that specified patient selection criteria based on her research findings.

The Approval: Four months after the RFE response was filed.

Key Lesson: An RFE on Criterion 5 is almost always asking the same question: "How do we know this contribution mattered to anyone beyond the citing count?" The answer is not more citations — it is evidence of downstream adoption or practice change. The NCCN letter and the clinical trial design citations answered that question specifically.

Case Study 3: James Okonkwo — Fintech Founder, New York (Approved in 8 Months)

Background: James grew up in Lagos, Nigeria, earned his undergraduate degree in economics at the University of Lagos, completed an MBA at Harvard Business School, and co-founded a fintech company in New York that built credit infrastructure for African SMEs in the United States and West Africa. The company raised $47 million in Series B funding in 2023, had 40 employees, and processed over $200 million in annual lending volume. James held patents on the company's risk scoring algorithm and had been profiled in TechCrunch, Forbes Africa, and Bloomberg.

James had no academic publications, no conference program committee service, and no teaching role. Many attorneys he consulted said EB-1A was not for him. Lumova said something different: "Your criteria profile is non-traditional but viable. Here is what to build."

Criteria Claimed (Four):

Criterion 3 (Published Material): The Bloomberg profile from 2023 — a 2,400-word feature specifically on James and his credit scoring approach — combined with the Forbes Africa feature and the TechCrunch coverage of the Series B. Each article was about James's specific methodology and vision, not just about the company as a business.

Criterion 5 (Original Contributions): The risk scoring algorithm represented an original methodological contribution to underwriting for SMEs with limited credit history — a recognized gap in the fintech industry. Expert declarations from two fintech academics and one World Bank financial inclusion specialist described the contribution specifically. A World Bank working paper on SME financing in sub-Saharan Africa cited James's methodology by name.

Criterion 7 — Dropped from initial plan (not applicable to his field).

Criterion 8 (Critical Role): As co-founder and CEO of a company that had received $47M in institutional venture capital from named firms including a prominent pan-African technology fund and a top-tier US fintech venture firm, James's role was clearly leading. The organization's distinguished reputation was established through funding documentation, press coverage, and a letter from a venture partner at one of the lead investors.

Criterion 9 (High Salary): Total compensation of $680,000 including base, bonus, and the annualized value of vested equity, compared against BLS data for Chief Executive Officers in the New York-Newark-Jersey City MSA. BLS 90th percentile for CEOs in that MSA: $310,000. His placement was in the top 5% for his occupation and geography.

The RFE:

USCIS challenged the distinguished reputation of the organization under Criterion 8, noting that the company was private and the reputation documentation was primarily from the company's own materials.

The Response:

The response included: independent press coverage from Bloomberg and TechCrunch specifically analyzing the company's market position and investor backing; a letter from a named partner at the lead investor describing the due diligence process and the competitive market position of the company; a market analysis from a financial data firm showing the company's top-five position in the US immigrant SME lending market; and three additional independent expert declarations from fintech founders and academics who could attest to the company's reputation in the field without any prior relationship to James.

Approval: Four months after RFE response.

Key Lesson: Founders and executives at private companies face a consistent challenge: USCIS cannot verify their organization's prestige through obvious public records like stock prices or university rankings. The solution is third-party press coverage, investor documentation, and independent expert declarations — evidence that the organization's reputation is real and externally recognized, not just self-asserted.

Case Study 4: Sofia Reyes-Morales — Documentary Filmmaker, Los Angeles (Approved in 7 Months, No RFE)

Background: Sofia grew up in Guadalajara, Mexico, trained at the Centro de Capacitación Cinematográfica in Mexico City, and spent four years building her career in Los Angeles on an O-1A visa. Her documentary on environmental displacement had screened at Sundance (World Cinema Documentary Competition, official selection), Tribeca (Special Jury Mention), and IDFA — the International Documentary Film Festival Amsterdam, the world's largest documentary festival. The film had been acquired by Netflix and had generated significant critical press. She had won the Ariel Award (Mexico's national film award) for Best Documentary in 2021.

Criteria Claimed (Three):

Criterion 3 (Published Material): Dedicated feature profiles in the Los Angeles Times, The Guardian (UK), IndieWire, and Variety. Each article was substantively about Sofia's work and artistic approach, not just about the film as a commercial property. The LA Times piece ran 3,200 words. The Guardian piece ran internationally in both the print and digital editions.

Criterion 8 (Critical Role): As sole director and co-writer of a film that had been acquired by Netflix and screened at three of the world's most selective documentary festivals, Sofia's role was demonstrably critical — she was the creative author of the work itself. This criterion is unusual for artists but applicable when the "organization" is a production entity or studio relationship of documented prestige. Her Netflix acquisition agreement and the documented prestige of IDFA (2,500+ submissions, under 5% acceptance rate) established the context.

Criterion 10 (Commercial Success in Performing Arts): The Netflix acquisition figure (not disclosed publicly, but documented in the petition), combined with IDFA's prize award and documented total festival prize earnings of $85,000 across three festivals, established commercial success relative to the documentary field. A declaration from a documentary distribution specialist provided comparative data showing that fewer than 3% of documentary films produced globally achieve Netflix acquisition combined with IDFA selection.

The No-RFE Outcome:

Sofia's petition succeeded on three criteria with no RFE for one specific reason: every exhibit answered the same implicit question before USCIS could ask it. The Sundance exhibit included USCIS-accessible documentation of Sundance's submission volume and World Cinema Documentary competition ratio. The IDFA exhibit included IDFA's documented submission statistics. The Netflix acquisition documentation addressed the distinction between domestic and international acquisition value. The LA Times exhibit included the publication's Audit Bureau of Circulations certification.

Preemption, at every turn.

Key Lesson: Arts applicants frequently under-document the prestige of their venues, festivals, and publications. You know that Sundance is prestigious. Officer Chen may not. Give Officer Chen the evidence she needs to agree with what you already know.

What All Four Cases Have in Common

Despite radically different fields, career profiles, and nationalities, all four approvals share five structural elements:

1. Three to four deeply evidenced criteria, not the maximum possible.

Arjun claimed four, Priya four, James four (with one dropped during planning), Sofia three. None tried to claim every criterion that could arguably apply.

2. Independent expert declarations from people who did not know the petitioner personally.

All four petitions included at least three independent expert declarations. All four were from experts who knew the petitioner's work through the public record, not through personal relationship.

3. Every number had a context.

Citations had percentiles. Awards had selection ratios. Salaries had BLS comparisons. Press coverage had publication circulation data. No data point was left floating without a benchmark.

4. An explicit, synthesizing final merits argument.

All four petition briefs contained a dedicated section that argued the totality — not just enumerated the criteria.

5. Pre-emption of the most likely objection for each criterion.

Award prestige, organization distinction, salary comparison methodology, contribution significance — all four petitions proactively addressed the standard RFE triggers before they were raised.

Talk to Lumova About Your Profile

One question from every reader of this article: "Which case study is most like mine?"

The answer determines your evidence strategy. Lumova can help you map your career — your publications, your role, your recognition, your compensation — against the ten criteria and identify which of these patterns most closely applies to your situation. More importantly, it tells you where your evidence is strong enough and where you need development time before filing.

Ask Lumova which case study profile your career most resembles, and what evidence strategy that implies.

Start your case analysis →

(Lumova is educational only, not legal advice.)

Frequently Asked Questions

Do I need premium processing?

Not required. Premium processing guarantees a decision (approval, RFE, or denial) within fifteen business days for $2,805. It does not increase your chances of approval. It is worth considering if you have a time-sensitive reason for a faster decision — H-1B expiring, job change, travel requirements — but it has no effect on the substantive outcome.

What if my field doesn't have prestigious awards?

Criterion 1 is not required. Several of the case studies above built strong cases without it (Sofia's case did not use Criterion 1; James's case emphasized Criteria 3, 5, 8, and 9). Identify the three to four criteria that are actually achievable in your field rather than trying to fit your career into criteria that don't apply.

Can I use my O-1A approval as evidence?

Yes, as supplementary evidence. O-1A uses a lower standard than EB-1A (distinction vs. sustained national/international acclaim), so an O-1A approval does not automatically establish EB-1A eligibility — but it is a useful corroborating data point that USCIS has previously determined you meet at least the "distinction" threshold in your field.

What if my case is complicated by a prior denial or RFE?

A prior denial does not prevent you from refiling. A stronger, more well-documented petition filed after the denial can succeed where the original failed. The key is understanding specifically why the first petition was denied — the denial notice provides that — and materially addressing those specific deficiencies. Consult an attorney before refiling after a denial.